Title: Yi-Hsiu Lin: Innovator in Cancer Treatment
Introduction
Yi-Hsiu Lin is an inventor based in New Taipei, Taiwan. He is associated with Trineo Biotechnology Co. Ltd. Although he currently holds no granted patents, his work focuses on innovative methods for cancer treatment. His research aims to provide new therapeutic options for patients suffering from cancer associated with galectin-1.
Latest Patent Applications
Yi-Hsiu Lin's notable patent application is titled "Method for Treating a Cancer Associated with the Activation of Galectin-1." This application presents a method for the treatment and/or prophylaxis of cancer linked to galectin-1. The method involves administering a pharmaceutical composition primarily composed of ganoderic acid S (GAS) and ganoderic acid T (GAT). Additionally, it includes the option to administer another anti-cancer agent before, together with, or after the main pharmaceutical composition to synergistically suppress cancer growth.
Conclusion
Yi-Hsiu Lin is a dedicated inventor working on innovative cancer treatment methods. His research has the potential to contribute significantly to the field of oncology.